Authors
Jérémie Gautheron, Mihael Vucur, Florian Reisinger, David Vargas Cardenas, Christoph Roderburg, Christiane Koppe, Karina Kreggenwinkel, Anne Theres Schneider, Matthias Bartneck, Ulf Peter Neumann, Ali Canbay, Helen Louise Reeves, Mark Luedde, Frank Tacke, Christian Trautwein, Mathias Heikenwalder, Tom Luedde
Publication date
2014/8
Journal
EMBO molecular medicine
Volume
6
Issue
8
Pages
1062-1074
Description
Non‐alcoholic fatty liver disease (NAFLD) represents the most common liver disease in Western countries and often progresses to non‐alcoholic steatohepatitis (NASH) leading ultimately to liver fibrosis and liver cancer. The occurrence of hepatocyte cell death—so far characterized as hepatocyte apoptosis—represents a fundamental step from benign steatosis toward progressive steatohepatitis. In contrast, the function of RIP3‐dependent “necroptosis” in NASH and NASH‐induced fibrosis is currently unknown. We show that RIP3 is upregulated in human NASH and in a dietary mouse model of steatohepatitis. RIP3 mediates liver injury, inflammation, induction of hepatic progenitor cells/activated cholangiocytes, and liver fibrosis through a pathway suppressed by Caspase‐8. This function of RIP3 is mediated by a positive feedback loop involving activation of Jun‐(N)‐terminal Kinase (JNK). Furthermore, RIP3 …
Total citations
20142015201620172018201920202021202220232024326293336293331313618
Scholar articles